222 related articles for article (PubMed ID: 29506105)
21. Incidence of Bowel Surgery and Associated Risk Factors in Pediatric-Onset Crohn's Disease.
Rinawi F; Assa A; Hartman C; Mozer Glassberg Y; Friedler VN; Rosenbach Y; Silbermintz A; Zevit N; Shamir R
Inflamm Bowel Dis; 2016 Dec; 22(12):2917-2923. PubMed ID: 27755214
[TBL] [Abstract][Full Text] [Related]
22. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease.
Picco MF; Zubiaurre I; Adluni M; Cangemi JR; Shelton D
Am J Gastroenterol; 2009 Nov; 104(11):2754-9. PubMed ID: 19584832
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcomes of intestinal penetrating Crohn's disease following successful nonoperative management.
Sun Z; Cao L; Chen Y; Zhu W; Li Y
Eur J Gastroenterol Hepatol; 2024 Jul; 36(7):867-874. PubMed ID: 38625818
[TBL] [Abstract][Full Text] [Related]
24. Risk Stratification for Surgery in Stricturing Ileal Crohn's Disease: The BACARDI Risk Model.
Bossuyt P; Debeuckelaere C; Ferrante M; de Buck van Overstraeten A; Vanbeckevoort D; Billiet T; Wolthuis A; Cleynen I; Van Assche G; D'Hoore A; Vermeire S
J Crohns Colitis; 2018 Jan; 12(1):32-38. PubMed ID: 28981768
[TBL] [Abstract][Full Text] [Related]
25. Patients With Stricturing or Penetrating Crohn's Disease Phenotypes Report High Disease Burden and Treatment Needs.
Fan Y; Zhang L; Omidakhsh N; Bohn RL; Thompson JS; Brodovicz KG; Deepak P
Inflamm Bowel Dis; 2023 Jun; 29(6):914-922. PubMed ID: 35880838
[TBL] [Abstract][Full Text] [Related]
26. The operative risk and natural history after the diagnosis of ileal penetrating Crohn's disease.
Bossuyt P; Debeuckelaere C; Ferrante M; Vanbeckevoort D; Billiet T; Wolthuis A; van Assche G; D'Hoore A; Vermeire S
Eur J Gastroenterol Hepatol; 2018 May; 30(5):539-545. PubMed ID: 29462028
[TBL] [Abstract][Full Text] [Related]
27. Penetrating Disease, Narcotic Use, and Loop Ostomy Are Associated with Ostomy and IBD-related Complications After Ostomy Surgery in Crohn's Disease Patients.
Hirsch A; Yarur AJ; Dezheng H; Rodriquez D; Krugliak Cleveland N; Ali T; Hurst RD; Umanskiy K; Hyman N; Colwell J; Rubin DT
J Gastrointest Surg; 2015 Oct; 19(10):1852-61. PubMed ID: 26264361
[TBL] [Abstract][Full Text] [Related]
28. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project.
Cleynen I; González JR; Figueroa C; Franke A; McGovern D; Bortlík M; Crusius BJ; Vecchi M; Artieda M; Szczypiorska M; Bethge J; Arteta D; Ayala E; Danese S; van Hogezand RA; Panés J; Peña SA; Lukas M; Jewell DP; Schreiber S; Vermeire S; Sans M
Gut; 2013 Nov; 62(11):1556-65. PubMed ID: 23263249
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with progression to surgery in Crohn's disease patients with endoscopic stricture.
Mao R; Chen BL; He Y; Cui Y; Zeng ZR; Chen MH
Endoscopy; 2014 Nov; 46(11):956-62. PubMed ID: 25325683
[TBL] [Abstract][Full Text] [Related]
30. Clinical features and long-term prognosis of Crohn's disease in Korea.
Ye BD; Yang SK; Cho YK; Park SH; Yang DH; Yoon SM; Kim KJ; Byeon JS; Myung SJ; Yu CS; Kim JH
Scand J Gastroenterol; 2010 Oct; 45(10):1178-85. PubMed ID: 20560811
[TBL] [Abstract][Full Text] [Related]
31. Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn's disease.
Bourgonje AR; Alexdottir MS; Otten AT; Loveikyte R; Bay-Jensen AC; Pehrsson M; van Dullemen HM; Visschedijk MC; Festen EAM; Weersma RK; Karsdal MA; Faber KN; Mortensen JH; Dijkstra G
Aliment Pharmacol Ther; 2022 Aug; 56(4):675-693. PubMed ID: 35661188
[TBL] [Abstract][Full Text] [Related]
32. Long-Term Follow-up and Predictors of Complicated Disease Behavior in Pediatric Crohn's Disease Patients.
Kori M; Avidan M; Topf-Olivestone C
J Pediatr Gastroenterol Nutr; 2022 Apr; 74(4):471-475. PubMed ID: 34984988
[TBL] [Abstract][Full Text] [Related]
33. Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study.
Burisch J; Kiudelis G; Kupcinskas L; Kievit HAL; Andersen KW; Andersen V; Salupere R; Pedersen N; Kjeldsen J; D'Incà R; Valpiani D; Schwartz D; Odes S; Olsen J; Nielsen KR; Vegh Z; Lakatos PL; Toca A; Turcan S; Katsanos KH; Christodoulou DK; Fumery M; Gower-Rousseau C; Zammit SC; Ellul P; Eriksson C; Halfvarson J; Magro FJ; Duricova D; Bortlik M; Fernandez A; Hernández V; Myers S; Sebastian S; Oksanen P; Collin P; Goldis A; Misra R; Arebi N; Kaimakliotis IP; Nikuina I; Belousova E; Brinar M; Cukovic-Cavka S; Langholz E; Munkholm P;
Gut; 2019 Mar; 68(3):423-433. PubMed ID: 29363534
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology and Natural History of Perianal Crohn's Disease: A Systematic Review and Meta-Analysis of Population-Based Cohorts.
Tsai L; McCurdy JD; Ma C; Jairath V; Singh S
Inflamm Bowel Dis; 2022 Oct; 28(10):1477-1484. PubMed ID: 34792604
[TBL] [Abstract][Full Text] [Related]
35. Incidence and clinical course of Crohn's disease during the first year - results from the IBD Cohort of the Uppsala Region (ICURE) of Sweden 2005-2009.
Sjöberg D; Holmström T; Larsson M; Nielsen AL; Holmquist L; Ekbom A; Rönnblom A
J Crohns Colitis; 2014 Mar; 8(3):215-22. PubMed ID: 24035547
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of fibrostenosing inflammatory bowel disease.
Mak JWY; Ng SC
J Dig Dis; 2020 Jun; 21(6):332-335. PubMed ID: 32105396
[TBL] [Abstract][Full Text] [Related]
37. The Effect of Early-Life Environmental Exposures on Disease Phenotype and Clinical Course of Crohn's Disease in Children.
Lindoso L; Mondal K; Venkateswaran S; Somineni HK; Ballengee C; Walters TD; Griffiths A; Noe JD; Crandall W; Snapper S; Rabizadeh S; Rosh JR; LeLeiko N; Guthery S; Mack D; Kellermayer R; Gulati AS; Pfefferkorn MD; Moulton DE; Keljo D; Cohen S; Oliva-Hemker M; Heyman MB; Otley A; Baker SS; Evans JS; Kirschner BS; Patel AS; Ziring D; Stephens MC; Baldassano R; Dubinsky MC; Markowitz J; Denson LA; Hyams J; Kugathasan S; Ananthakrishnan AN
Am J Gastroenterol; 2018 Oct; 113(10):1524-1529. PubMed ID: 30267029
[TBL] [Abstract][Full Text] [Related]
38. Serum Protein Biomarkers of Fibrosis Aid in Risk Stratification of Future Stricturing Complications in Pediatric Crohn's Disease.
Wu J; Lubman DM; Kugathasan S; Denson LA; Hyams JS; Dubinsky MC; Griffiths AM; Baldassano RN; Noe JD; Rabizadeh S; Gulati AS; Rosh JR; Crandall WV; Higgins PDR; Stidham RW
Am J Gastroenterol; 2019 May; 114(5):777-785. PubMed ID: 31058681
[TBL] [Abstract][Full Text] [Related]
39. Clinical features and risk factors for primary surgery in 205 patients with Crohn's disease: analysis of a South China cohort.
Song XM; Gao X; Li MZ; Chen ZH; Chen SC; Hu PJ; He YL; Zhan WH; Chen MH
Dis Colon Rectum; 2011 Sep; 54(9):1147-54. PubMed ID: 21825896
[TBL] [Abstract][Full Text] [Related]
40. Adalimumab in Biologic-naïve Patients With Crohn's Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAID.
Bouhnik Y; Pineton de Chambrun G; Lambert J; Nachury M; Seksik P; Altwegg R; Vuitton L; Stefanescu C; Nancey S; Aubourg A; Serrero M; Filippi J; Desseaux K; Viennot S; Abitbol V; Boualit M; Bourreille A; Giletta C; Buisson A; Roblin X; Dib N; Malamut G; Amiot A; Fumery M; Louis E; Elgharabawy Y; Peyrin-Biroulet L;
Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3365-3378.e5. PubMed ID: 36731588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
